M&A / Deals RoosterBio and MineBio team up to expand MSC solutions access in China Pharmaceutical Business ReviewMineBio will supply RoosterBio's complete platform of products, having already obtained import clearance.M&A / DealsRead full story pharminent April 8, 2026 (Last updated: April 8, 2026) Pharmaceutical Business Review MineBio will supply RoosterBio’s complete platform of products, having already obtained import clearance. M&A / DealsRead full story Post navigation Previous: Halozyme and Vertex sign deal for Hypercon technologyNext: EU invests 30m to fight antimicrobial resistance Related Stories M&A / Deals Solstice Oncology secures $225m to drive porustobart’s development for cancer pharminent September 10, 2026 M&A / Deals UK’s Claret Capital raises 575m for European biotechs pharminent September 7, 2026 M&A / Deals GSK wagers up to $1.3B on a different kind of cancer drug pharminent September 3, 2026